Brief: Heat Biologics Announces Survival Data Of Hs-110 In Two Treatment Settings Of Lung Cancer Selected For Presentation At 2021 American Society Of Clinical Oncology Annual Meeting
20/05/2021 12:48
May 20 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS ANNOUNCES PROMISING SURVIVAL DATA OF HS-110
IN
TWO TREATMENT SETTINGS OF LUNG CANCER; SELECTED FOR PRESENTATION
AT 2021 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING
Source text for Eikon: ID:nGNX9sRdsG
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company